Cargando…
Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
BACKGROUND: Brazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The analysis of ARV price evolution and market dynamics in Brazil can help anticipate issues soon to affli...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156239/ https://www.ncbi.nlm.nih.gov/pubmed/21858138 http://dx.doi.org/10.1371/journal.pone.0023478 |